Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion type Assertion NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_head.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion description "[Targeting the PI3K/AKT/pathway with small molecule inhibitors in combination with chemotherapy could be exploited as a novel strategy in the treatment of liposarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_provenance.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion evidence source_evidence_literature NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_provenance.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion SIO_000772 24695632 NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_provenance.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion wasDerivedFrom befree-20150227 NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_provenance.
- NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_assertion wasGeneratedBy ECO_0000203 NP622494.RAXgn3mJ9VOlA6PEvwWo8saUWld1ryORUtmu5N9kHiSYw130_provenance.